Director, Portfolio Strategy

Summit Therapeutics

14h•$190,000 - $237,000

About The Position

The Director, Portfolio Strategy reports to the Vice President, Product Portfolio Strategy and Competitive Intelligence. The role supports strategic planning by assessing existing and potential markets and competitors and providing actionable recommendations. The Director leads new-indication and disease-area strategy for oncology, particularly solid tumors, and works cross-functionally to guide late-stage clinical development and portfolio decisions. The position also partners with Business Development on external opportunities and provides analytical support to executive stakeholders.

Requirements

Bachelor’s degree in biotechnology or a related field.
12+ years of pharmaceutical or biotechnology industry experience working with qualitative and quantitative research in oncology or pharmaceutical markets, with emphasis on non-small cell lung cancer, colorectal cancer, and other solid tumors.
Strong understanding of the solid tumor oncology landscape, including portfolio strategy, market planning, competitive intelligence, forecasting, and therapeutic areas such as lung and colorectal cancer.
Ability to identify and collect relevant market, customer, and competitor data; perform quantitative and qualitative analyses; and translate complex findings into actionable insights and strategic recommendations.
Experience leading and executing end-to-end market research, including designing research plans, synthesizing findings, and presenting results.
Experience with advanced spreadsheets, patient-based forecasting models including dynamic patient models, and NPV modeling.
Experience facilitating competitive workshops and developing TPPs with program and study teams.
Experience with market research and organizing findings in databases.
Strong communication and presentation skills.
Skill with PowerPoint, Excel, and similar data tools.
Ability to travel up to 30% of the time, depending on business needs.

Nice To Haves

Advanced degree (MS or PhD).
Experience conducting primary and secondary market research with exposure to global markets.

Responsibilities

Lead new-indication strategy and planning across oncology indications, working with Clinical, Regulatory, Commercial, and other functions to guide late-stage clinical development strategy.
Develop and refine frameworks and processes for new-indication and overall portfolio strategy; provide thought leadership and support strategic and investment decisions.
Deliver market and competitive intelligence through research, scenario planning, and impact assessments to inform executive decisions and portfolio strategy.
Develop integrated disease-area strategies and market assessments for new solid tumor indications in partnership with R&D, Clinical, Medical, Commercial, Business Development, and Program teams.
Partner with the Business Development team to provide strategic direction on business development and external collaboration opportunities.
Analyze competitors, products, and market trends; track landscape changes and translate insights into strategic implications for launches and pipeline indications.
Develop, lead, and execute qualitative, quantitative, and competitive market research plans, including vendor selection, study design, interpretation, and delivery of results.
Develop NPV, forecasting, and revenue models for new indications up to 18 months before launch to inform early commercial planning.
Lead target product profile (TPP) development and alignment with cross-functional teams for solid tumor indications.
Use analytical methodologies and tools to interpret epidemiology, market, and customer data and produce actionable recommendations.
Integrate market research and competitive intelligence into strategic planning, including brand plans, market access, and situation analyses.
Maintain understanding of oncology markets and data sources and synthesize findings into a central knowledge repository.
Provide ad hoc analytical support to executive stakeholders for R&D, commercial, and business development decisions.
Build and manage external partnerships, including market research vendors and data providers, ensuring quality, accountability, and cost-effectiveness.